Free Trial
LON:AREC

Arecor Therapeutics 4/22/2025 Earnings Report

Arecor Therapeutics logo
GBX 37 -1.00 (-2.63%)
As of 05/7/2025 09:50 AM Eastern

Arecor Therapeutics EPS Results

Actual EPS
-GBX 0.31
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Arecor Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Arecor Therapeutics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Arecor Therapeutics Earnings Headlines

This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
Arecor Full Year 2024 Trading Update
See More Arecor Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arecor Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arecor Therapeutics and other key companies, straight to your email.

About Arecor Therapeutics

Arecor Therapeutics (LON:AREC) is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com

View Arecor Therapeutics Profile

More Earnings Resources from MarketBeat